Jinyu Bio-technology's share price uptick may be positive, but market expectations of EPS growth were higher three years ago. Flat revenue and small yield suggest share price doesn't reflect the top line. The company's underperformance over the past year indicates unresolved challenges. Investors should monitor fundamentals and be aware of risks.
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Jinyu Bio-Technology Stock Forum
No comment yet